ClinicalTrials.gov record
Completed Phase 3 Interventional

Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease

ClinicalTrials.gov ID: NCT00482092

Public ClinicalTrials.gov record NCT00482092. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 11:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multicenter, Placebo-controlled, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of PROCHYMAL® (ex Vivo Cultured Adult Human Mesenchymal Stem Cells) Intravenous Infusion for the Induction of Remission in Subjects Experiencing Treatment-refractory Moderate-to-severe Crohn's Disease

Study identification

NCT ID
NCT00482092
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Mesoblast, Inc.
Industry
Enrollment
330 participants

Conditions and interventions

Conditions

Not listed

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 16, 2007
Primary completion
Sep 14, 2014
Completion
Sep 14, 2014
Last update posted
Mar 10, 2026

2007 – 2014

United States locations

U.S. sites
10
U.S. states
6
U.S. cities
10
Facility City State ZIP Site status
University of Southern California University Hospital Los Angeles California 90033
University of California, San Francisco San Francisco California 94115
Western States Clinical Research Wheat Ridge Colorado 80033
Clinical Research of West Florida Clearwater Florida 33765
Borland-Groover Clinic Jacksonville Florida 32256
Shafran Gastroenterology Center Winter Park Florida 32789
Atlanta Gastroenterology Associates Atlanta Georgia 30342
University of Chicago Medical Center Chicago Illinois 60637
Carle Clinic Association Urbana Illinois 61801
Indiana University Medical Center Indianapolis Indiana 46202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00482092, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 10, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00482092 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →